Miconazole Tzf (Miconazole)

Miconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for ergosterol synthesis. Without ergosterol, the fungal cell membrane becomes unstable, leading to increased permeability and cell death, thereby clearing the infection.

The dosage regimen for Miconazole Tzf is determined by the prescribing healthcare professional based on the infection type, severity, patient age and other clinical factors. Patients should follow the prescriber’s instructions and the product label.

Safety data for topical miconazole during pregnancy and lactation are limited. Healthcare providers usually weigh potential benefits against risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their physician before starting treatment.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Miconazole belongs to the imidazole class and offers broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, miconazole has a similar efficacy for many skin infections but may be preferred for its anti‑inflammatory properties and ease of formulation in creams or powders.

Miconazole Tzf should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from excessive heat, moisture and direct sunlight to maintain stability and potency.

The product is applied topically to the affected skin area, usually once or twice daily, after cleaning and drying the site. A thin layer should be spread over the lesion and surrounding skin, and hands washed after application. Follow the prescriber’s directions for duration of therapy.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, extensive skin blistering, Stevens‑Johnson syndrome, and toxic epidermal necrolysis. Immediate medical attention is required if signs of a severe reaction develop.

Individuals with a known hypersensitivity to miconazole or any component of the formulation should avoid using the product. It is also contraindicated on large areas of broken skin, near the eyes, or in patients who have experienced severe cutaneous reactions to topical azoles.